Applied DNA Sciences Inc is part of the consulting and outsourcing industry and industrials sector. The company CEO is James A. Hayward. Applied DNA Sciences Inc creates security solutions addressing the challenges of supply chain security, brand protection or law enforcement applications.
Previous Intraday Performance:
The APDN shares had a previous change of 1.26% which opened at 0.68 and closed at 0.65. It moved to an intraday high of 0.68 and a low of 0.64.
Over the last five trading days, APDN shares returned -0.72% and in the past 30 trading days it returned 1.28%. Over three months, it changed 43.69%. In one year it has changed -54.53% and within that year its 52-week high was 1.84 and its 52-week low was 0.30. APDN stock is 116.73% above its 52 Week Low.
Our calculations result in a 200 day moving average of 0.98 and a 50 day moving average of 0.61. Right now, APDN stock is trading -33.84% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.
The company has a market cap of $24.0m with 36.8m shares outstanding and a float of 18.9m shares. Trading volume was 102,790 shares and has experienced an average volume of 628,740 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
The last annual reported EPS for Applied DNA Sciences Inc was -0.41 which ended on 30th of September 2018.
The next earnings report will be: 05-09-2019
The growth of the EPS is critical in understanding the current valuation of Applied DNA Sciences Inc; the EPS growth rate, as it is typically called, is usually expressed as a percentage, which at this time is hard to estimate, but revenue growth has been -17.40% over the last twelve months.
Indicators Also to Watch:
Based on the latest filings, there is 59.50% of insider ownership and 8.40% of institutional ownership.
I calculated the beta to be 0.72
Based on last reported financials, the company’s return on equity is -263.77%, return on assets is -149.05%, price-to-sales is 7.64 and price-to-book is 31.28.
Company Score Card:
Results are out of six:
2 : Growth Expectations Result
2 : Financial Safety Result
0 : Past Performance Result
0 : Valuation Result
0 : Dividend Safety Result
1 : Overall Result